| Association of initial disease-modifying therapy with later conversion to secondary progressive multiple sclerosis JWL Brown, A Coles, D Horakova, E Havrdova, G Izquierdo, A Prat, ... Jama 321 (2), 175-187, 2019 | 492 | 2019 |
| Defining secondary progressive multiple sclerosis J Lorscheider, K Buzzard, V Jokubaitis, T Spelman, E Havrdova, ... Brain 139 (9), 2395-2405, 2016 | 410 | 2016 |
| Pediatric multiple sclerosis: a review R Alroughani, A Boyko BMC neurology 18, 1-8, 2018 | 241 | 2018 |
| Associations of disease-modifying therapies with COVID-19 severity in multiple sclerosis S Simpson-Yap, E De Brouwer, T Kalincik, N Rijke, JA Hillert, C Walton, ... Neurology 97 (19), e1870-e1885, 2021 | 229 | 2021 |
| Defining reliable disability outcomes in multiple sclerosis T Kalincik, G Cutter, T Spelman, V Jokubaitis, E Havrdova, D Horakova, ... Brain 138 (11), 3287-3298, 2015 | 211 | 2015 |
| Sex as a determinant of relapse incidence and progressive course of multiple sclerosis T Kalincik, V Vivek, V Jokubaitis, J Lechner-Scott, M Trojano, G Izquierdo, ... Brain 136 (12), 3609-3617, 2013 | 203 | 2013 |
| Male sex is independently associated with faster disability accumulation in relapse-onset MS but not in primary progressive MS KA Ribbons, P McElduff, C Boz, M Trojano, G Izquierdo, P Duquette, ... PloS one 10 (6), e0122686, 2015 | 199 | 2015 |
| Switch to natalizumab versus fingolimod in active relapsing–remitting multiple sclerosis T Kalincik, D Horakova, T Spelman, V Jokubaitis, M Trojano, A Lugaresi, ... Annals of Neurology 77 (3), 425-435, 2015 | 189 | 2015 |
| Treatment effectiveness of alemtuzumab compared with natalizumab, fingolimod, and interferon beta in relapsing-remitting multiple sclerosis: a cohort study T Kalincik, JWL Brown, N Robertson, M Willis, N Scolding, CM Rice, ... The Lancet Neurology 16 (4), 271-281, 2017 | 173 | 2017 |
| Fingolimod after natalizumab and the risk of short-term relapse VG Jokubaitis, V Li, T Kalincik, G Izquierdo, S Hodgkinson, R Alroughani, ... Neurology 82 (14), 1204-1211, 2014 | 157 | 2014 |
| Migraine among medical students in Kuwait University JY Al-Hashel, SF Ahmed, R Alroughani, PJ Goadsby The journal of headache and pain 15, 1-6, 2014 | 134 | 2014 |
| Comparison of switch to fingolimod or interferon beta/glatiramer acetate in active multiple sclerosis A He, T Spelman, V Jokubaitis, E Havrdova, D Horakova, M Trojano, ... JAMA neurology 72 (4), 405-413, 2015 | 130 | 2015 |
| Diagnosis and classification of optic neuritis A Petzold, CL Fraser, M Abegg, R Alroughani, D Alshowaeir, R Alvarenga, ... The Lancet Neurology 21 (12), 1120-1134, 2022 | 127 | 2022 |
| Relapse occurrence in women with multiple sclerosis during pregnancy in the new treatment era R Alroughani, MS Alowayesh, SF Ahmed, R Behbehani, J Al-Hashel Neurology 90 (10), e840-e846, 2018 | 127 | 2018 |
| Towards personalized therapy for multiple sclerosis: prediction of individual treatment response T Kalincik, A Manouchehrinia, L Sobisek, V Jokubaitis, T Spelman, ... Brain 140 (9), 2426-2443, 2017 | 116 | 2017 |
| Increasing prevalence and incidence rates of multiple sclerosis in Kuwait R Alroughani, SF Ahmed, R Behbehani, R Khan, A Thussu, KJ Alexander, ... Multiple Sclerosis Journal 20 (5), 543-547, 2014 | 113 | 2014 |
| Discontinuing disease-modifying therapy in MS after a prolonged relapse-free period: a propensity score-matched study I Kister, T Spelman, R Alroughani, J Lechner-Scott, P Duquette, ... Journal of Neurology, Neurosurgery & Psychiatry 87 (10), 1133-1137, 2016 | 106 | 2016 |
| Seasonal variation of relapse rate in multiple sclerosis is latitude dependent T Spelman, O Gray, M Trojano, T Petersen, G Izquierdo, A Lugaresi, ... Annals of neurology 76 (6), 880-890, 2014 | 106 | 2014 |
| Risk of relapse phenotype recurrence in multiple sclerosis T Kalincik, K Buzzard, V Jokubaitis, M Trojano, P Duquette, G Izquierdo, ... Multiple Sclerosis Journal 20 (11), 1511-1522, 2014 | 106 | 2014 |
| Higher latitude is significantly associated with an earlier age of disease onset in multiple sclerosis C Tao, S Simpson, I Van Der Mei, L Blizzard, E Havrdova, D Horakova, ... Journal of Neurology, Neurosurgery & Psychiatry 87 (12), 1343-1349, 2016 | 100 | 2016 |
Alessandra LugaresiDept Biomedical and Neuromotor Sciences - Univ. "Alma Mater Studiorum" of Bologna在 unibo.it 的电子邮件经过验证
